60 Degrees Pharmaceuticals Inc reported a strategic collaboration with GoodRx that will make discounted pricing available for its malaria prevention medication ARAKODA (tafenoquine). The company said eligible consumers can receive savings of up to 30% on the prescription drug, with access beginning February 2, 2026.
The arrangement will allow patients to obtain ARAKODA at over 70,000 pharmacies nationwide through GoodRx’s platform, or to have the drug delivered to their homes when delivery is available, according to the announcement. ARAKODA is described as the only FDA-approved, once-weekly prescription medication for malaria prevention currently on the U.S. market.
Following the release of the partnership details, 60 Degrees Pharmaceuticals' stock experienced a marked decline, falling 16.9% in premarket trading on Monday. The company, which focuses on developing therapies for vector-borne diseases, did not provide additional guidance in the announcement accompanying the GoodRx collaboration.
ARAKODA, whose active ingredient is tafenoquine, was discovered by the Walter Reed Army Institute of Research and received FDA approval in 2018. The drug is primarily prescribed for travelers who are headed to regions where malaria is endemic. Clinically, the medicine is notable for a long terminal half-life of approximately 16 days, which supports less-frequent dosing compared with some alternative malaria prophylaxis options.
The standard dosing schedule for ARAKODA consists of a loading phase and a maintenance phase: two 100mg tablets taken daily for three days prior to travel; followed by two 100mg tablets taken weekly while traveling, for up to six months; and concluding with two 100mg tablets in the week after travel.
Company officials framed the GoodRx arrangement as a means to expand discounted access to ARAKODA for eligible consumers, while market participants reacted negatively in early trading. The announcement leaves certain execution details - such as the scope of eligibility and the timing and availability of home delivery - subject to the terms described in the partnership notice.
Summary
- 60 Degrees Pharmaceuticals formed a partnership with GoodRx to offer up to 30% savings on ARAKODA starting Feb. 2, 2026.
- The program will make discounts available at more than 70,000 pharmacies and via home delivery when available.
- Following the announcement, the company's stock fell 16.9% in premarket trading.